| Symbol |
Name |
Standardized Value |
|
COL17A1
|
collagen, type XVII, alpha 1
|
4.0
|
|
DST
|
dystonin
|
4.0
|
|
DSG3
|
desmoglein 3
|
3.328
|
|
DSG1
|
desmoglein 1
|
3.315
|
|
LAMA3
|
laminin, alpha 3
|
2.799
|
|
DPP4
|
dipeptidyl-peptidase 4
|
2.709
|
|
PPL
|
periplakin
|
2.682
|
|
PLEC
|
plectin
|
2.618
|
|
EVPL
|
envoplakin
|
2.599
|
|
IL5
|
interleukin 5
|
2.435
|
|
IL4
|
interleukin 4
|
2.428
|
|
IL31
|
interleukin 31
|
2.419
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
2.407
|
|
IL17A
|
interleukin 17A
|
2.376
|
|
IL13
|
interleukin 13
|
2.374
|
|
CD4
|
CD4 molecule
|
2.351
|
|
DSP
|
desmoplakin
|
2.345
|
|
C3
|
complement component 3
|
2.302
|
|
PDCD1
|
programmed cell death 1
|
2.275
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
2.271
|
|
TNF
|
tumor necrosis factor
|
2.237
|
|
CD274
|
CD274 molecule
|
2.234
|
|
IFNG
|
interferon, gamma
|
2.208
|
|
RNASE3
|
ribonuclease, RNase A family, 3
|
2.195
|
|
CD8A
|
CD8a molecule
|
2.172
|
|
IL6
|
interleukin 6
|
2.171
|
|
KRT3
|
keratin 3, type II
|
2.139
|
|
KRT12
|
keratin 12, type I
|
2.138
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
2.137
|
|
IL1B
|
interleukin 1, beta
|
2.129
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
2.12
|
|
ITGB4
|
integrin, beta 4
|
2.113
|
|
A2ML1
|
alpha-2-macroglobulin-like 1
|
2.103
|
|
DSC3
|
desmocollin 3
|
2.1
|
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha
|
2.093
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
2.092
|
|
ELANE
|
elastase, neutrophil expressed
|
2.073
|
|
MMP9
|
matrix metallopeptidase 9
|
2.067
|
|
TNFRSF25
|
tumor necrosis factor receptor superfamily, member 25
|
2.044
|
|
IL10
|
interleukin 10
|
2.043
|
|
IL2
|
interleukin 2
|
2.02
|
|
IL1A
|
interleukin 1, alpha
|
2.017
|
|
TSLP
|
thymic stromal lymphopoietin
|
2.011
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
2.01
|
|
C5AR1
|
complement component 5a receptor 1
|
1.999
|
|
IL4R
|
interleukin 4 receptor
|
1.997
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
1.955
|
|
TGFB1
|
transforming growth factor, beta 1
|
1.946
|
|
CCL26
|
chemokine (C-C motif) ligand 26
|
1.929
|
|
DSC1
|
desmocollin 1
|
1.925
|
|
ITGA6
|
integrin, alpha 6
|
1.891
|
|
DR1
|
down-regulator of transcription 1, TBP-binding (negative cofactor 2)
|
1.886
|
|
RNASE2
|
ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin)
|
1.856
|
|
FOXP3
|
forkhead box P3
|
1.845
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
1.837
|
|
IL22
|
interleukin 22
|
1.833
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
1.818
|
|
FN1
|
fibronectin 1
|
1.811
|
|
FLG2
|
filaggrin family member 2
|
1.811
|
|
FLG
|
filaggrin
|
1.804
|
|
EPPK1
|
epiplakin 1
|
1.799
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
1.779
|
|
IL31RA
|
interleukin 31 receptor A
|
1.778
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
1.747
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
1.739
|
|
CRP
|
C-reactive protein, pentraxin-related
|
1.73
|
|
EPX
|
eosinophil peroxidase
|
1.727
|
|
PLG
|
plasminogen
|
1.72
|
|
IL3
|
interleukin 3
|
1.72
|
|
IL5RA
|
interleukin 5 receptor, alpha
|
1.717
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
1.716
|
|
C5AR2
|
complement component 5a receptor 2
|
1.707
|
|
RNF103
|
ring finger protein 103
|
1.707
|
|
ALB
|
albumin
|
1.707
|
|
CDH17
|
cadherin 17, LI cadherin (liver-intestine)
|
1.688
|
|
C1S
|
complement component 1, s subcomponent
|
1.683
|
|
PKP3
|
plakophilin 3
|
1.68
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
1.679
|
|
EGF
|
epidermal growth factor
|
1.674
|
|
MPO
|
myeloperoxidase
|
1.674
|
|
DSC2
|
desmocollin 2
|
1.672
|
|
CCL18
|
chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated)
|
1.669
|
|
CCR3
|
chemokine (C-C motif) receptor 3
|
1.666
|
|
ANXA9
|
annexin A9
|
1.656
|
|
IFNA1
|
interferon, alpha 1
|
1.655
|
|
TPO
|
thyroid peroxidase
|
1.654
|
|
TAC1
|
tachykinin, precursor 1
|
1.654
|
|
ACE
|
angiotensin I converting enzyme
|
1.648
|
|
IVL
|
involucrin
|
1.646
|
|
COL7A1
|
collagen, type VII, alpha 1
|
1.642
|
|
CD40LG
|
CD40 ligand
|
1.641
|
|
IL33
|
interleukin 33
|
1.64
|
|
KRT14
|
keratin 14, type I
|
1.637
|
|
DPP8
|
dipeptidyl-peptidase 8
|
1.632
|
|
INS
|
insulin
|
1.619
|
|
ICAM1
|
intercellular adhesion molecule 1
|
1.617
|
|
CD80
|
CD80 molecule
|
1.614
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
1.612
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
1.606
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
1.596
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
1.592
|
|
KRT4
|
keratin 4, type II
|
1.585
|
|
C4A
|
complement component 4A (Rodgers blood group)
|
1.574
|
|
FIP1L1
|
factor interacting with PAPOLA and CPSF1
|
1.572
|
|
KRT13
|
keratin 13, type I
|
1.564
|
|
POSTN
|
periostin, osteoblast specific factor
|
1.562
|
|
CFP
|
complement factor properdin
|
1.561
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
1.561
|
|
CMA1
|
chymase 1, mast cell
|
1.559
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
1.554
|
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
1.55
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
1.549
|
|
IL9
|
interleukin 9
|
1.549
|
|
OSMR
|
oncostatin M receptor
|
1.543
|
|
KRT15
|
keratin 15, type I
|
1.542
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
1.536
|
|
TGM2
|
transglutaminase 2
|
1.534
|
|
DPP9
|
dipeptidyl-peptidase 9
|
1.534
|
|
SYK
|
spleen tyrosine kinase
|
1.533
|
|
PXDN
|
peroxidasin
|
1.519
|
|
PXDNL
|
peroxidasin-like
|
1.518
|
|
DSG4
|
desmoglein 4
|
1.504
|
|
FGF7
|
fibroblast growth factor 7
|
1.493
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
1.492
|
|
TACR1
|
tachykinin receptor 1
|
1.492
|
|
LAMB3
|
laminin, beta 3
|
1.489
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
1.488
|
|
PAX6
|
paired box 6
|
1.486
|
|
PRTN3
|
proteinase 3
|
1.484
|
|
CCL24
|
chemokine (C-C motif) ligand 24
|
1.48
|
|
CD19
|
CD19 molecule
|
1.479
|
|
MRGPRX2
|
MAS-related GPR, member X2
|
1.471
|
|
TOR1A
|
torsin family 1, member A (torsin A)
|
1.469
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
1.468
|
|
JAK1
|
Janus kinase 1
|
1.467
|
|
IL15
|
interleukin 15
|
1.46
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
1.459
|
|
CD151
|
CD151 molecule (Raph blood group)
|
1.456
|
|
SIGLEC8
|
sialic acid binding Ig-like lectin 8
|
1.454
|
|
LTF
|
lactotransferrin
|
1.45
|
|
CD86
|
CD86 molecule
|
1.447
|
|
IL17F
|
interleukin 17F
|
1.44
|
|
CD28
|
CD28 molecule
|
1.436
|
|
HRH4
|
histamine receptor H4
|
1.436
|
|
LACRT
|
lacritin
|
1.435
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
1.427
|
|
MUC16
|
mucin 16, cell surface associated
|
1.425
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
1.422
|
|
LAMC2
|
laminin, gamma 2
|
1.421
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
1.42
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
1.419
|
|
KRT5
|
keratin 5, type II
|
1.416
|
|
PRG2
|
proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein)
|
1.412
|
|
RAG2
|
recombination activating gene 2
|
1.41
|
|
CLC
|
Charcot-Leyden crystal galectin
|
1.408
|
|
CRLF2
|
cytokine receptor-like factor 2
|
1.407
|
|
PDCD1LG2
|
programmed cell death 1 ligand 2
|
1.4
|
|
FCAR
|
Fc fragment of IgA receptor
|
1.399
|
|
CCL22
|
chemokine (C-C motif) ligand 22
|
1.397
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
1.396
|
|
IL18
|
interleukin 18
|
1.396
|
|
IL16
|
interleukin 16
|
1.395
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
1.394
|
|
IL17RA
|
interleukin 17 receptor A
|
1.393
|
|
POMC
|
proopiomelanocortin
|
1.39
|
|
CCL13
|
chemokine (C-C motif) ligand 13
|
1.389
|
|
LAMA4
|
laminin, alpha 4
|
1.389
|
|
NID1
|
nidogen 1
|
1.389
|
|
SELE
|
selectin E
|
1.389
|
|
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
|
1.387
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
1.384
|
|
ELN
|
elastin
|
1.384
|
|
GCG
|
glucagon
|
1.38
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
1.378
|
|
F8
|
coagulation factor VIII, procoagulant component
|
1.375
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
1.371
|
|
TRIM21
|
tripartite motif containing 21
|
1.37
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
1.37
|
|
PDE4A
|
phosphodiesterase 4A, cAMP-specific
|
1.367
|
|
SELL
|
selectin L
|
1.365
|
|
IL7
|
interleukin 7
|
1.36
|
|
F2
|
coagulation factor II (thrombin)
|
1.357
|
|
CD1C
|
CD1c molecule
|
1.352
|
|
MMP3
|
matrix metallopeptidase 3
|
1.351
|
|
H6PD
|
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)
|
1.35
|
|
IFNA2
|
interferon, alpha 2
|
1.349
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
1.349
|
|
TNFSF12
|
tumor necrosis factor (ligand) superfamily, member 12
|
1.348
|
|
MUC7
|
mucin 7, secreted
|
1.347
|
|
HSP90AB1
|
heat shock protein 90kDa alpha (cytosolic), class B member 1
|
1.343
|
|
CD163
|
CD163 molecule
|
1.341
|
|
TG
|
thyroglobulin
|
1.337
|
|
CD1B
|
CD1b molecule
|
1.336
|
|
IL36RN
|
interleukin 36 receptor antagonist
|
1.334
|
|
TGM3
|
transglutaminase 3
|
1.332
|
|
EGFR
|
epidermal growth factor receptor
|
1.332
|
|
C4B
|
complement component 4B (Chido blood group)
|
1.332
|
|
SERPINH1
|
serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1)
|
1.331
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
1.327
|
|
TNFRSF12A
|
tumor necrosis factor receptor superfamily, member 12A
|
1.322
|
|
GNLY
|
granulysin
|
1.314
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
1.313
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
1.308
|
|
IL24
|
interleukin 24
|
1.308
|
|
FCGR1A
|
Fc fragment of IgG, high affinity Ia, receptor (CD64)
|
1.307
|
|
CXCR5
|
chemokine (C-X-C motif) receptor 5
|
1.304
|
|
MUC1
|
mucin 1, cell surface associated
|
1.303
|
|
KERA
|
keratocan
|
1.303
|
|
CTSG
|
cathepsin G
|
1.297
|
|
MMP2
|
matrix metallopeptidase 2
|
1.296
|
|
CD1D
|
CD1d molecule
|
1.295
|
|
VTN
|
vitronectin
|
1.295
|
|
TLR2
|
toll-like receptor 2
|
1.294
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
1.294
|
|
PTGDR2
|
prostaglandin D2 receptor 2
|
1.293
|
|
MUC4
|
mucin 4, cell surface associated
|
1.293
|
|
TLR9
|
toll-like receptor 9
|
1.292
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
1.291
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
1.29
|
|
KRT1
|
keratin 1, type II
|
1.289
|
|
ICOS
|
inducible T-cell co-stimulator
|
1.288
|
|
CD69
|
CD69 molecule
|
1.286
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
1.285
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
1.283
|
|
CD1E
|
CD1e molecule
|
1.279
|
|
HSPG2
|
heparan sulfate proteoglycan 2
|
1.278
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
1.278
|
|
KITLG
|
KIT ligand
|
1.275
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
1.271
|
|
CCRL2
|
chemokine (C-C motif) receptor-like 2
|
1.269
|
|
ATP4A
|
ATPase, H+/K+ exchanging, alpha polypeptide
|
1.269
|
|
CD1A
|
CD1a molecule
|
1.268
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
1.268
|
|
LTB4R
|
leukotriene B4 receptor
|
1.266
|
|
KRT19
|
keratin 19, type I
|
1.264
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
1.264
|
|
ATP12A
|
ATPase, H+/K+ transporting, nongastric, alpha polypeptide
|
1.263
|
|
PRF1
|
perforin 1 (pore forming protein)
|
1.259
|
|
CCR6
|
chemokine (C-C motif) receptor 6
|
1.258
|
|
TLR4
|
toll-like receptor 4
|
1.255
|
|
FGF10
|
fibroblast growth factor 10
|
1.254
|
|
MMP1
|
matrix metallopeptidase 1
|
1.252
|
|
COL4A3
|
collagen, type IV, alpha 3 (Goodpasture antigen)
|
1.25
|
|
FGF22
|
fibroblast growth factor 22
|
1.249
|
|
FCER1A
|
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide
|
1.249
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
1.248
|
|
SSB
|
Sjogren syndrome antigen B (autoantigen La)
|
1.248
|
|
FGF16
|
fibroblast growth factor 16
|
1.247
|
|
KRT10
|
keratin 10, type I
|
1.242
|
|
MATN1
|
matrilin 1, cartilage matrix protein
|
1.241
|
|
MMP8
|
matrix metallopeptidase 8
|
1.239
|
|
FGF6
|
fibroblast growth factor 6
|
1.238
|
|
FGF20
|
fibroblast growth factor 20
|
1.236
|
|
FGF17
|
fibroblast growth factor 17
|
1.234
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
1.231
|
|
FGF18
|
fibroblast growth factor 18
|
1.23
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
1.23
|
|
FGF5
|
fibroblast growth factor 5
|
1.23
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
1.228
|
|
ADAM9
|
ADAM metallopeptidase domain 9
|
1.226
|
|
TCF15
|
transcription factor 15 (basic helix-loop-helix)
|
1.226
|
|
FGF3
|
fibroblast growth factor 3
|
1.225
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
1.223
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
1.222
|
|
FGF9
|
fibroblast growth factor 9
|
1.221
|
|
TLR7
|
toll-like receptor 7
|
1.218
|
|
TGFB2
|
transforming growth factor, beta 2
|
1.217
|
|
SPINK5
|
serine peptidase inhibitor, Kazal type 5
|
1.216
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
1.216
|
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
1.215
|
|
FGF4
|
fibroblast growth factor 4
|
1.215
|
|
CD5
|
CD5 molecule
|
1.212
|
|
CARD14
|
caspase recruitment domain family, member 14
|
1.207
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
1.206
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
1.205
|
|
C5
|
complement component 5
|
1.203
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
1.201
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
1.2
|
|
TPMT
|
thiopurine S-methyltransferase
|
1.197
|
|
IFNA5
|
interferon, alpha 5
|
1.196
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
1.196
|
|
CD27
|
CD27 molecule
|
1.193
|
|
IFNA4
|
interferon, alpha 4
|
1.192
|
|
GATA3
|
GATA binding protein 3
|
1.189
|
|
IFNA16
|
interferon, alpha 16
|
1.188
|
|
IFNA7
|
interferon, alpha 7
|
1.187
|
|
IFNA14
|
interferon, alpha 14
|
1.187
|
|
IFNA21
|
interferon, alpha 21
|
1.187
|
|
IFNA10
|
interferon, alpha 10
|
1.187
|
|
IFNA6
|
interferon, alpha 6
|
1.186
|
|
HRH1
|
histamine receptor H1
|
1.186
|
|
IFNA8
|
interferon, alpha 8
|
1.186
|
|
CXCL11
|
chemokine (C-X-C motif) ligand 11
|
1.185
|
|
IFNA13
|
interferon, alpha 13
|
1.184
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
1.181
|
|
IFNA17
|
interferon, alpha 17
|
1.179
|
|
MACF1
|
microtubule-actin crosslinking factor 1
|
1.179
|
|
KNG1
|
kininogen 1
|
1.176
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
1.175
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
1.175
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
1.174
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
1.172
|
|
IL7R
|
interleukin 7 receptor
|
1.169
|
|
JAK2
|
Janus kinase 2
|
1.165
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
1.164
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
1.163
|
|
GIP
|
gastric inhibitory polypeptide
|
1.163
|
|
PKP1
|
plakophilin 1
|
1.163
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
1.162
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
1.16
|
|
MMP12
|
matrix metallopeptidase 12
|
1.159
|
|
TNFRSF13C
|
tumor necrosis factor receptor superfamily, member 13C
|
1.159
|
|
VIP
|
vasoactive intestinal peptide
|
1.158
|
|
TGM1
|
transglutaminase 1
|
1.158
|
|
TNFSF4
|
tumor necrosis factor (ligand) superfamily, member 4
|
1.157
|
|
LAG3
|
lymphocyte-activation gene 3
|
1.157
|
|
JAK3
|
Janus kinase 3
|
1.146
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
1.143
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
1.143
|
|
CD44
|
CD44 molecule (Indian blood group)
|
1.143
|
|
CXCL5
|
chemokine (C-X-C motif) ligand 5
|
1.143
|
|
TGFA
|
transforming growth factor, alpha
|
1.141
|
|
LTA
|
lymphotoxin alpha
|
1.14
|
|
IL1R1
|
interleukin 1 receptor, type I
|
1.14
|
|
CD200
|
CD200 molecule
|
1.137
|
|
IL26
|
interleukin 26
|
1.133
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
1.132
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
1.131
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
1.13
|
|
CD207
|
CD207 molecule, langerin
|
1.128
|
|
GLP1R
|
glucagon-like peptide 1 receptor
|
1.127
|
|
CCL1
|
chemokine (C-C motif) ligand 1
|
1.125
|
|
B2M
|
beta-2-microglobulin
|
1.125
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
1.124
|
|
FERMT1
|
fermitin family member 1
|
1.123
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
1.121
|
|
MYD88
|
myeloid differentiation primary response 88
|
1.117
|
|
ITGAE
|
integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide)
|
1.116
|
|
IL36R
|
interleukin 36 receptor
|
1.114
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
1.113
|
|
AIRE
|
autoimmune regulator
|
1.111
|
|
TNFRSF4
|
tumor necrosis factor receptor superfamily, member 4
|
1.11
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
1.109
|
|
CD68
|
CD68 molecule
|
1.106
|
|
THBS1
|
thrombospondin 1
|
1.103
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
1.103
|
|
CPA3
|
carboxypeptidase A3 (mast cell)
|
1.1
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
1.1
|
|
IL25
|
interleukin 25
|
1.098
|
|
DHFR2
|
dihydrofolate reductase 2
|
1.098
|
|
CCN2
|
cellular communication network factor 2
|
1.093
|
|
LOC102723996
|
ICOS ligand
|
1.09
|
|
CARD9
|
caspase recruitment domain family, member 9
|
1.09
|
|
ATP2C1
|
ATPase, Ca++ transporting, type 2C, member 1
|
1.09
|
|
RBP3
|
retinol binding protein 3, interstitial
|
1.088
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
1.087
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
1.086
|
|
TYK2
|
tyrosine kinase 2
|
1.081
|
|
GALNT6
|
polypeptide N-acetylgalactosaminyltransferase 6
|
1.077
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
1.075
|
|
LCE3B
|
late cornified envelope 3B
|
1.07
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
1.069
|
|
CD63
|
CD63 molecule
|
1.065
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
1.064
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
1.062
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
1.06
|
|
CD52
|
CD52 molecule
|
1.059
|
|
VWF
|
von Willebrand factor
|
1.058
|
|
COL4A6
|
collagen, type IV, alpha 6
|
1.052
|
|
TP53
|
tumor protein p53
|
1.052
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
1.051
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
1.051
|
|
PF4
|
platelet factor 4
|
1.048
|
|
LPP
|
LIM domain containing preferred translocation partner in lipoma
|
1.047
|
|
TBX21
|
T-box 21
|
1.046
|
|
GPR15
|
G protein-coupled receptor 15
|
1.045
|
|
IL17RC
|
interleukin 17 receptor C
|
1.044
|
|
CD276
|
CD276 molecule
|
1.044
|
|
AQP5
|
aquaporin 5
|
1.042
|
|
CCL19
|
chemokine (C-C motif) ligand 19
|
1.041
|
|
C1R
|
complement component 1, r subcomponent
|
1.036
|
|
CD34
|
CD34 molecule
|
1.034
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
1.034
|
|
IL36A
|
interleukin 36, alpha
|
1.033
|
|
S100A7
|
S100 calcium binding protein A7
|
1.026
|
|
CPA4
|
carboxypeptidase A4
|
1.023
|
|
CCL7
|
chemokine (C-C motif) ligand 7
|
1.021
|
|
LAMC1
|
laminin, gamma 1 (formerly LAMB2)
|
1.02
|
|
EXPH5
|
exophilin 5
|
1.02
|
|
DHFR
|
dihydrofolate reductase
|
1.016
|
|
MASP2
|
mannan-binding lectin serine peptidase 2
|
1.014
|
|
HLA-DQA2
|
major histocompatibility complex, class II, DQ alpha 2
|
1.013
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
1.012
|
|
HSPA4
|
heat shock 70kDa protein 4
|
1.011
|
|
TSHR
|
thyroid stimulating hormone receptor
|
1.009
|
|
WDR11
|
WD repeat domain 11
|
1.009
|
|
TYR
|
tyrosinase
|
1.008
|
|
IL23R
|
interleukin 23 receptor
|
1.004
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
1.002
|
|
TLR3
|
toll-like receptor 3
|
1.0
|
